🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
STT
$STTK
🔒 US EquitiesShattuck Labs In
AVG HISTORICAL GAP
-0.55%
MAX GAP RECORD
-5.57%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $STTK
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$STTK
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 12, 2026 Earnings Release 2026-08-12 (AFTER CLOSE) |
+2.14%
|
| May 07, 2026 Earnings Release 2026-05-07 (BEFORE OPEN) |
-0.45%
|
| Mar 05, 2026 Earnings Release 2026-03-05 (BEFORE OPEN) |
-3.59%
|
| Nov 06, 2025 Earnings Release 2025-11-06 (AFTER CLOSE) |
-3.57%
|
| Aug 14, 2025 Earnings Release 2025-08-14 (BEFORE OPEN) |
-1.36%
|
| Apr 30, 2025 Earnings Release 2025-04-30 (AFTER CLOSE) |
+0.00%
|
| Nov 14, 2024 Earnings Release 2024-11-14 (BEFORE OPEN) |
+2.46%
|
| Aug 01, 2024 Earnings Release 2024-08-01 (AFTER CLOSE) |
-5.57%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
2.9%
Bullish Gaps (5)
Bearish Gaps (5)
Neutral / Flat (2)
📖 Intelligence Summary
Shattuck Labs, Inc. is a clinical-stage biotechnology company, which engages in the research and development of potential treatments for inflammatory and immune-mediated diseases. It focuses on developing a potential first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company was founded by…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗